CTI BioPharma to Present at the 20th Annual Needham Virtual Healthcare Conference on Wednesday, Apr. 14

<br /> CTI BioPharma to Present at the 20th Annual Needham Virtual Healthcare Conference on Wednesday, Apr. 14<br />

PR Newswire


SEATTLE

,

April 7, 2021

/PRNewswire/ — CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the 20th Annual Needham Virtual Healthcare Conference at

3:00 p.m. EST

. The conference will be held in a virtual meeting format.

Presentation details:

Event: 20th Annual Needham Virtual Healthcare Conference

Date:

Wednesday, April 14, 2021


Time:

3:00 p.m. EST

The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma’s website at

www.ctibiopharma.com

.


About CTI BioPharma Corp.

We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on evaluating pacritinib, our sole product candidate currently in active late-stage development, for the treatment of adult patients with myelofibrosis. In addition, we have recently started developing pacritinib for use in hospitalized patients with severe COVID-19, in response to the COVID-19 pandemic. We are headquartered in

Seattle, Washington

.


CTI BioPharma Investor Contacts:


Maghan Meyers

+212-600-1902


[email protected]

Cision
View original content to download multimedia:

http://www.prnewswire.com/news-releases/cti-biopharma-to-present-at-the-20th-annual-needham-virtual-healthcare-conference-on-wednesday-apr-14-301263743.html

SOURCE CTI BioPharma Corp.